|
2025-06-23 |
2025-06-20 |
V
Vente
|
Yaffe Kristine
Administrateur non-exécutif
|
1 000
-1.0%
1,44
1 440 USD
|
1 000
-1.0%
|
1,44
|
100 000 USD
|
|
|
2025-06-04 |
2025-06-02 |
V
Vente
|
Kenkare-Mitra Sara
President and Head of R&D
Dirigeant
|
23 890
-4.5%
1,34
31 974 USD
|
23 890
-4.5%
|
1,34
|
31 974 USD
|
|
|
2025-06-04 |
2025-06-02 |
V
Vente
|
GRASSO MARC
Chief Financial Officer
Dirigeant
|
16 488
-5.3%
1,34
22 068 USD
|
16 488
-5.3%
|
1,34
|
22 068 USD
|
|
|
2025-06-04 |
2025-06-02 |
V
Vente
|
Rosenthal Arnon
Chief Executive Officer
Administrateur exécutif
|
52 087
-2.1%
1,34
69 713 USD
|
52 087
-2.1%
|
1,34
|
69 713 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
GRASSO MARC
Chief Financial Officer
Dirigeant
|
18 091
-5.5%
1,47
26 547 USD
|
18 091
-5.5%
|
1,47
|
26 547 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Romano Gary
Chief Medical Officer
Dirigeant
|
16 306
-4.7%
1,47
23 927 USD
|
16 306
-4.7%
|
1,47
|
23 927 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Rosenthal Arnon
Chief Executive Officer
Administrateur exécutif
|
40 330
-1.6%
1,47
59 176 USD
|
40 330
-1.6%
|
1,47
|
59 176 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Kenkare-Mitra Sara
President and Head of R&D
Dirigeant
|
29 073
-5.1%
1,47
42 662 USD
|
29 073
-5.1%
|
1,47
|
42 662 USD
|
|
|
2024-12-03 |
2024-12-02 |
V
Vente
|
GRASSO MARC
Chief Financial Officer
Dirigeant
|
16 489
-4.7%
2,52
41 542 USD
|
16 489
-4.7%
|
2,52
|
41 542 USD
|
|
|
2024-12-03 |
2024-12-02 |
V
Vente
|
Romano Gary
Chief Medical Officer
Dirigeant
|
14 892
-4.1%
2,52
37 519 USD
|
14 892
-4.1%
|
2,52
|
37 519 USD
|
|
|
2024-12-03 |
2024-12-02 |
V
Vente
|
Kenkare-Mitra Sara
President and Head of R&D
Dirigeant
|
26 500
-4.5%
2,52
66 764 USD
|
26 500
-4.5%
|
2,52
|
66 764 USD
|
|
|
2024-12-03 |
2024-12-02 |
V
Vente
|
Rosenthal Arnon
Chief Executive Officer
Administrateur exécutif
|
52 172
-2.0%
2,52
131 442 USD
|
52 172
-2.0%
|
2,52
|
131 442 USD
|
|
|
2024-09-04 |
2024-09-03 |
V
Vente
|
Kenkare-Mitra Sara
President and Head of R&D
Dirigeant
|
13 926
-4.6%
4,88
67 981 USD
|
13 926
-4.6%
|
4,88
|
67 981 USD
|
|
|
2024-09-04 |
2024-09-03 |
V
Vente
|
Rosenthal Arnon
Chief Executive Officer
Administrateur exécutif
|
26 499
-1.3%
4,88
129 387 USD
|
26 499
-1.3%
|
4,88
|
129 387 USD
|
|
|
2024-09-04 |
2024-09-03 |
V
Vente
|
Romano Gary
Chief Medical Officer
Dirigeant
|
8 478
-4.5%
4,88
41 385 USD
|
8 478
-4.5%
|
4,88
|
41 385 USD
|
|
|
2024-09-04 |
2024-09-03 |
V
Vente
|
GRASSO MARC
Chief Financial Officer
Dirigeant
|
7 297
-5.3%
4,88
35 620 USD
|
7 297
-5.3%
|
4,88
|
35 620 USD
|
|
|
2024-08-23 |
2024-08-22 |
V
Vente
|
SCHELLER RICHARD H
Administrateur non-exécutif
|
44 250
-55.8%
5,16
228 388 USD
|
44 250
-55.8%
|
5,16
|
228 388 USD
|
|
|
2024-08-13 |
2024-08-12 |
VP
Vente planifiée
|
Yaffe Kristine
Administrateur non-exécutif
|
5 000
-6.9%
5,06
25 309 USD
|
5 000
-6.9%
|
5,06
|
25 309 USD
|
|
|
2024-08-13 |
2024-08-12 |
VP
Vente planifiée
|
Hammond Paula
Administrateur non-exécutif
|
10 500
-14.8%
5,06
53 179 USD
|
10 500
-14.8%
|
5,06
|
53 179 USD
|
|
|
2024-06-04 |
2024-06-03 |
V
Vente
|
GRASSO MARC
Chief Financial Officer
Dirigeant
|
6 920
-4.8%
4,80
33 208 USD
|
6 920
-4.8%
|
4,80
|
33 208 USD
|
|
